372 related articles for article (PubMed ID: 33954428)
1. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
[TBL] [Abstract][Full Text] [Related]
2. Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics.
Tilton CS; Johnson SW
Am J Infect Control; 2019 Mar; 47(3):280-284. PubMed ID: 30318399
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
Johnson SW; Brown SV; Priest DH
Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
[TBL] [Abstract][Full Text] [Related]
4. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
mBio; 2020 May; 11(3):. PubMed ID: 32371595
[No Abstract] [Full Text] [Related]
5. Evidence of within-facility patient-patient
Justice S; Sewell DK; Li H; Miller AC; Polgreen PM
Epidemiol Infect; 2022 Dec; 151():e4. PubMed ID: 36502810
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
[TBL] [Abstract][Full Text] [Related]
7. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
Yu H; Flaster N; Casanello AL; Curcio D
Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic prediction models to identify patients at risk for healthcare-facility-onset
Patterson WM; Fajnzylber J; Nero N; Hernandez AV; Deshpande A
Infect Control Hosp Epidemiol; 2024 Feb; 45(2):174-181. PubMed ID: 37665104
[TBL] [Abstract][Full Text] [Related]
9. Shift to community-onset Clostridium difficile infection in the national Veterans Health Administration, 2003-2014.
Reveles KR; Pugh MJV; Lawson KA; Mortensen EM; Koeller JM; Argamany JR; Frei CR
Am J Infect Control; 2018 Apr; 46(4):431-435. PubMed ID: 29126751
[TBL] [Abstract][Full Text] [Related]
10. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
[TBL] [Abstract][Full Text] [Related]
11. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
[TBL] [Abstract][Full Text] [Related]
12. Investigating the association of room features with healthcare-facility-onset
Root ED; Lindstrom M; Xie A; Mangino JE; Moffatt-Bruce S; Hebert C
Infect Control Hosp Epidemiol; 2021 Jul; 42(7):847-852. PubMed ID: 33261688
[TBL] [Abstract][Full Text] [Related]
13. Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.
Polat M; Tapısız A; Demirdağ TB; Yayla BC; Kara SS; Tezer H; Belet N; Çırak MY
Am J Infect Control; 2023 Aug; 51(8):879-883. PubMed ID: 36535316
[TBL] [Abstract][Full Text] [Related]
14. Healthcare associated
Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
[No Abstract] [Full Text] [Related]
15. Residual effect of community antimicrobial exposure on risk of hospital onset healthcare-associated Clostridioides difficile infection: a case-control study using national linked data.
Pan J; Kavanagh K; Marwick C; Davey P; Wuiff C; Bryson S; Robertson C; Bennie M
J Hosp Infect; 2019 Nov; 103(3):259-267. PubMed ID: 31173780
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
17. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
19. SEASON GAP score: A predictor of Clostridioides difficile infection among patients with tube feeding.
Masaki M; Matsuo T; Kobayashi D; Mori N
J Infect Chemother; 2022 Aug; 28(8):1131-1137. PubMed ID: 35440369
[TBL] [Abstract][Full Text] [Related]
20. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
Adams DJ; Barone JB; Nylund CM
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
